These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 19711542)
21. Global collaborations in leprosy research--the future is connected. Dockrell HM; Oskam L; Richardus JH Lepr Rev; 2008 Dec; 79(4):358-60. PubMed ID: 19274982 [No Abstract] [Full Text] [Related]
22. [Development and future of medical research in Poland]. Wołk R Kardiol Pol; 2008 Jul; 66(7):808-11. PubMed ID: 18807655 [No Abstract] [Full Text] [Related]
23. [Development and future of medical research in Poland - commentary]. Grzybowski A Kardiol Pol; 2008 Sep; 66(9):1024-5. PubMed ID: 19004120 [No Abstract] [Full Text] [Related]
24. [The future of clinical risk management after COVID-19 pandemic]. Paci E; Filomena C Epidemiol Prev; 2021; 45(1-2):19. PubMed ID: 33884836 [No Abstract] [Full Text] [Related]
25. [The newly revised Declaration of Helsinki: what do the changes mean from an ethical perspective?]. Rid A; Schmidt H Dtsch Med Wochenschr; 2009 Dec; 134(49):2525-8. PubMed ID: 19941238 [TBL] [Abstract][Full Text] [Related]
26. Tourette syndrome research in Europe has entered a new era of collaboration. Hoekstra PJ; Dietrich A Eur Child Adolesc Psychiatry; 2015 Feb; 24(2):125-6. PubMed ID: 25650008 [No Abstract] [Full Text] [Related]
27. [Reaction on 'Assessment and management of the risk for violence']. Goethals K; van Lier E Tijdschr Psychiatr; 2009; 51(6):423-4. PubMed ID: 19517373 [No Abstract] [Full Text] [Related]
28. [Structure of the meeting of the german radiological society and scientific discourse pertaining to radiation dose and dose reduction: an analysis of 1998 - 2008]. Heyer CM; Peters S; Lemburg S Rofo; 2009 Nov; 181(11):1065-72. PubMed ID: 19830643 [TBL] [Abstract][Full Text] [Related]
29. [Risk analysis in radiotherapy]. Francois P; Lartigau E Cancer Radiother; 2009 Oct; 13(6-7):574-80. PubMed ID: 19767227 [TBL] [Abstract][Full Text] [Related]
31. NIDCR looks to the future. Interview by Phillip Bonner. Kleinman D Dent Today; 2000 Apr; 19(4):112-7. PubMed ID: 19750737 [No Abstract] [Full Text] [Related]
32. Comment on the Capstone Depleted Uranium (DU) Aerosol Characterization and Risk Assessment Study. Lykken GI; Momcilović B Health Phys; 2010 Jan; 98(1):77; author reply 77-8. PubMed ID: 19959955 [No Abstract] [Full Text] [Related]
33. Landmark report could influence the future of medicines in Europe and the world. Saudi Med J; 2005 Apr; 26(4):696-7. PubMed ID: 18178983 [No Abstract] [Full Text] [Related]
34. Low-dose radiation epidemiology studies: status and issues. Shore RE Health Phys; 2009 Nov; 97(5):481-6. PubMed ID: 19820457 [TBL] [Abstract][Full Text] [Related]
36. At risk, who me? Identifying and managing risk in your practice. Possanza LB Del Med J; 2009 Mar; 81(3):131-3. PubMed ID: 19507763 [No Abstract] [Full Text] [Related]
37. Non-targeted effects of ionizing radiation: implications for risk assessment and the radiation dose response profile. Morgan WF; Sowa MB Health Phys; 2009 Nov; 97(5):426-32. PubMed ID: 19820452 [TBL] [Abstract][Full Text] [Related]
38. Brain research in Europe. Mendlewicz J Science; 1993 Jan; 259(5094):442. PubMed ID: 8481201 [No Abstract] [Full Text] [Related]